Secondary Sulfonamides as Effective Lactoperoxidase Inhibitors
AbstractSecondary sulfonamides (4a–8h) incorporating acetoxybenzamide, triacetoxybenzamide, hydroxybenzamide, and trihydroxybenzamide and possessing thiazole, pyrimidine, pyridine, isoxazole and thiadiazole groups were synthesized. Lactoperoxidase (LPO, E.C.18.104.22.168), as a natural antibacterial agent, is a peroxidase enzyme secreted from salivary, mammary, and other mucosal glands. In the present study, the in vitro inhibitory effects of some secondary sulfonamide derivatives (4a–8h) were examined against LPO. The obtained results reveal that secondary sulfonamide derivatives (4a–8h) are effective LPO inhibitors. The Ki values of secondary sulfonamide derivatives (4a–8h) were found in the range of 1.096 × 10−3 to 1203.83 µM against LPO. However, the most effective inhibition was found for N-(sulfathiazole)-3,4,5-triacetoxybenzamide (6a), with Ki values of 1.096 × 10−3 ± 0.471 × 10−3 µM as non-competitive inhibition. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Köksal, Z.; Kalin, R.; Camadan, Y.; Usanmaz, H.; Almaz, Z.; Gülçin, İ.; Gokcen, T.; Gören, A.C.; Ozdemir, H. Secondary Sulfonamides as Effective Lactoperoxidase Inhibitors. Molecules 2017, 22, 793.
Köksal Z, Kalin R, Camadan Y, Usanmaz H, Almaz Z, Gülçin İ, Gokcen T, Gören AC, Ozdemir H. Secondary Sulfonamides as Effective Lactoperoxidase Inhibitors. Molecules. 2017; 22(6):793.Chicago/Turabian Style
Köksal, Zeynep; Kalin, Ramazan; Camadan, Yasemin; Usanmaz, Hande; Almaz, Züleyha; Gülçin, İlhami; Gokcen, Taner; Gören, Ahmet C.; Ozdemir, Hasan. 2017. "Secondary Sulfonamides as Effective Lactoperoxidase Inhibitors." Molecules 22, no. 6: 793.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.